Yolanda Armero

Validated Risk Score for Predicting 6‐Month Mortality in Infective Endocarditis

Lawrence P. Park, Vivian H. Chu, Gail Peterson et al. · Journal of the American Heart Association · 2016 · 199 citations · Full text

High-Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Endocarditis

José M. Miró, José M. Entenza, Ana del Rı́o et al. · Antimicrobial Agents and Chemotherapy · 2012 · 123 citations · Full text

Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone

Juan M. Pericàs, Carlos Cervera, Asunción Moreno et al. · Clinical Microbiology and Infection · 2014 · 97 citations · Full text

Last 15, Antimicrobial Susceptibility, Health Sciences +9

Efficacy and Safety of Fosfomycin Plus Imipenem as Rescue Therapy for Complicated Bacteremia and Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: A Multicenter Clinical Trial

Ana del Río Lechuga, Oriol Gasch, Asunción Moreno et al. · Clinical Infectious Diseases · 2014 · 87 citations · Full text

Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate <i>Staphylococcus epidermidis</i>

C. García-de-la-Mària, Francesc Marco, Yolanda Armero et al. · Antimicrobial Agents and Chemotherapy · 2010 · 68 citations · Full text